Operating Cash Flow
Amgen Operating Cash Flow increased by 36.6% to $2.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 57.4%, from $1.39B to $2.19B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a 1.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Detailed definition
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Peer comparison
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.93B | $2.42B | $2.81B | $2.16B | $1.93B | $2.98B | $2.65B | $1.06B | $4.11B | $2.76B | $538.00M | $689.00M | $2.46B | $3.57B | $4.77B | $1.39B | $2.28B | $4.68B | $1.60B | $2.19B |
| QoQ Change | — | +25.2% | +16.1% | -22.9% | -10.8% | +54.3% | -11.0% | -59.8% | +286.2% | -32.8% | -80.5% | +28.1% | +256.9% | +45.2% | +33.6% | -70.8% | +63.9% | +105.4% | -65.8% | +36.6% |
| YoY Change | — | — | — | — | -0.1% | +23.2% | -5.7% | -50.8% | +112.9% | -7.3% | -79.7% | -35.2% | -40.2% | +29.4% | +786.8% | +101.9% | -7.3% | +31.2% | -66.4% | +57.4% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Amgen's operating cash flow?
- Amgen (AMGN) reported operating cash flow of $2.19B in Q1 2026.
- How has Amgen's operating cash flow changed year-over-year?
- Amgen's operating cash flow increased by 57.4% year-over-year, from $1.39B to $2.19B.
- What is the long-term trend for Amgen's operating cash flow?
- Over 4 years (2021 to 2025), Amgen's operating cash flow has grown at a 1.8% compound annual growth rate (CAGR), from $9.26B to $9.96B.
- What does operating cash flow mean?
- The actual amount of cash a company brings in from its day-to-day business activities.